What we need to know about long-acting ß₂-agonists: déjà vu all over again?
作者信息
Arnold Donald H, Hartert Tina V
出版信息
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1219-20. doi: 10.1164/rccm.201006-0941ED.
PMID:21079266
Abstract
摘要
相似文献
1
What we need to know about long-acting ß₂-agonists: déjà vu all over again?关于长效β₂受体激动剂，我们需要了解些什么：似曾相识的感觉再度袭来？
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1219-20. doi: 10.1164/rccm.201006-0941ED.
2
Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol.长效β2受体激动剂在常规哮喘治疗中的安全性评估：ASTRO-LAB方案。
NPJ Prim Care Respir Med. 2015 Jun 18;25:15040. doi: 10.1038/npjpcrm.2015.40.
3
Combination treatment in asthma: Reviewing old and new options.哮喘的联合治疗：回顾新旧选择。
Pulm Pharmacol Ther. 2015 Oct;34:72-4. doi: 10.1016/j.pupt.2015.08.010. Epub 2015 Sep 10.
4
Should an inhaled corticosteroid accompany each dose of fast-acting beta2-agonist for relief of asthma symptoms?缓解哮喘症状时，每剂速效β2激动剂都应搭配吸入性糖皮质激素吗？
Paediatr Respir Rev. 2024 Jun;50:38-40. doi: 10.1016/j.prrv.2023.05.005. Epub 2024 Mar 29.
5
Mometasone/Formoterol (dulera) for asthma.莫米松/福莫特罗（信必可都保）用于治疗哮喘。
Med Lett Drugs Ther. 2010 Oct 18;52(1349):83-4.
6
[Not Available].[无可用内容]
Praxis (Bern 1994). 2018;107(21):1169-1170. doi: 10.1024/1661-8157/a003073.
7
Treatments for poorly controlled asthma.
BMJ. 2021 Oct 4;375:n2355. doi: 10.1136/bmj.n2355.
8
Long acting β2 agonists in adult asthma.长效β2受体激动剂在成人哮喘中的应用
BMJ. 2013 Aug 6;347:f4662. doi: 10.1136/bmj.f4662.
9
Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.评估噻托溴铵吸入剂在常规联合疗法控制不佳的哮喘中的作用。
Expert Opin Pharmacother. 2013 May;14(7):967-9. doi: 10.1517/14656566.2013.783015. Epub 2013 Mar 21.
10
[Asthma and COPD: guidance in the jungle of inhalative drugs].[哮喘与慢性阻塞性肺疾病：吸入药物丛林中的指南]
MMW Fortschr Med. 2015 May 28;157(10):59, 61-2. doi: 10.1007/s15006-015-3139-6.
引用本文的文献
1
Selecting the Optimal Therapy for Mild Asthma.为轻度哮喘选择最佳治疗方法。
Ann Am Thorac Soc. 2021 Dec;18(12):1955-1957. doi: 10.1513/AnnalsATS.202106-697ED.
Zotero 插件